- Received prior systemic anti-cancer therapy
|
-
Pregnant or breastfeeding at time of enrollment
|
-
Prior history and treatment for any invasive cancer within the past 5 years, with the exception of non-melanoma skin cancer
|
-
Has a known history of an inherited genetic condition associated with an increased risk of colorectal cancer, with the exception of Lynch Syndrome in Stage III patients
|
-
MMR deficient tumor or germline MMR deficiency (Lynch Syndrome) with Stage II colorectal cancer
|
-
Prior stem cell transplant
|